- Term and Contingency. The term of Phase B begins on the last day of Phase A through to the end of the term defined in Section 8.01 of the Lilly License. Entrance into Phase B is contingent on ADOLOR delivering to ▇▇▇▇▇▇▇ during the term of Phase A notice of ADOLOR’s intent to proceed with Phase B.
Appears in 1 contract
- Term and Contingency. The term of Phase B begins on the last day of Phase A through to the end of the term defined in Section 8.01 *Confidential Treatment Requested. Omitted portions filed with the Securities and Exchange Commission (the “Commission”). of the Lilly License. Entrance into Phase B is contingent on ADOLOR delivering to ▇▇▇▇▇▇▇ during the term of Phase A notice of ADOLOR’s intent to proceed with Phase B.
Appears in 1 contract
Sources: Option and License Agreement (Cubist Pharmaceuticals Inc)